By aligning internal operations with outsourced processes and offering hands-on QA management support, we ensured a smooth, compliant, and practical implementation
About this Case Study
This case study highlights how Rephine supported a fast-growing biotech company specialising in novel cancer biotherapeutics as it prepared to enter non-clinical and clinical trial phases. The company, recently spun out from two institutions, needed to establish a fully GMP-compliant Quality Management System (QMS) to support its Investigational Medicinal Product (IMP) operations.
Facing challenges such as a lack of internal GMP knowledge and key roles being managed by external consultants, the company required a flexible yet robust QMS tailored to its structure and regulatory needs. Rephine delivered a scalable system, embedded QA oversight, and ensured alignment across internal teams and outsourced partners—achieving full GxP readiness and preparing the client for regulatory inspections.
Download the full case study now and discover how Rephine helped a biotech company achieve GMP compliance for their IMP operations.
Download the Case Study
View other our other resources and company news
Blog Continuous Inspection Readiness Beyond Mock Audits
Blog How Rephine Accelerates Digital QMS Transformation in Pharma
Blog Threat Modelling in Medical Devices: STRIDE for MDR/IVDR Cybersecurity Compliance
Guide Security Risk Management for Medical Devices: MDR & IVDR Compliance Whitepaper
Case Study Pharmaceutical Equipment Qualification Case Study
Blog Equipment Qualification in the Pharmaceutical Industry: Lifecycle, Best Practices & Risk-Based Tips
Blog Digitalization in Pharma: GxP Compliance with Rephine
Blog Building a Strong Quality Culture in Pharma
Blog